The aim of this in vitro study was to ascertain the effect of recombinant human Fibroblast Growth Factor-18 (rhFGF18) on the repair response of mechanically damaged articular cartilage. Articular cartilage discs were harvested from healthy mature horses (n-=-4) and subjected to single impact load (SIL). The impacted explants, together with unimpacted controls were cultured in modified DMEM-±-200-ng/ml rhFGF18 for up to 30 days. Glycosaminoglycan (GAG) release into the media was measured using the dimethylmethylene blue (DMMB) assay. Aggrecan neopepitope CS846, collagen type II synthesis (CPII) and cleavage (C2C) were measured by ELISA. Histological analysis and TUNEL staining were used to assess repair cell number and cell death. Impacted explants treated with rhFGF18 showed significantly more GAG and CS846 release into the media (p-
CITATION STYLE
Barr, L., Getgood, A., Guehring, H., Rushton, N., & Henson, F. M. D. (2014). The effect of recombinant human fibroblast growth factor-18 on articular cartilage following single impact load. Journal of Orthopaedic Research, 32(7), 923–927. https://doi.org/10.1002/jor.22622
Mendeley helps you to discover research relevant for your work.